FLAM
OLMA icon

First Light Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

First Light Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-631,064
Closed -$8.85M – 73
2023
Q4 		$8.85M Buy
+631,064
New +$8.48M 0.71% 36

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

First Light Asset Management's OLMA Position: Q1 2024 in Review

First Light Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2024, closing a stake of 631,064 shares — an estimated $8.85M sold.

First Light Asset Management first reported a position in OLMA in Q4 2023 and held it in 1 quarter. The position peaked at $8.85M in Q4 2023. 126 funds tracked by Wall St. Rank hold OLMA as of Q1 2024.

  • First Light Asset Management reported no remaining Olema Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • First Light Asset Management sold 631,064 Olema Pharmaceuticals shares in Q1 2024, an estimated $8.85M.
  • First Light Asset Management first reported a position in Olema Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • First Light Asset Management's Olema Pharmaceuticals position peaked at $8.85M in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2024.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.